Literature DB >> 1660813

Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for V alpha 8-, V beta 2- or V beta 10-bearing T cells.

A Necker1, N Rebaï, M Matthes, E Jouvin-Marche, P A Cazenave, P Swarnworawong, E Palmer, H R MacDonald, B Malissen.   

Abstract

We have characterized a panel of monoclonal antibodies (mAb) produced by immunizing rats with two distinct soluble mouse alpha/beta T cell receptor (TcR). Fifty mAb were found to react with the corresponding surface-bound TcR. Such observations suggest that the soluble TcR molecules used as immunogen are folded in a conformation similar to the native structure. Furthermore, the binding to T cells of four antibodies was found to correlate with the expression of the V alpha 8, V beta 2 or V beta 10 gene segments. Finally, staining of T lymphocytes from various mouse strains suggests that (a) the two anti-V alpha 8 antibodies recognize different epitopes, and each on only a fraction of V alpha 8+ cells; (b) the anti-V beta 10 mAb identifies a V beta 10 polymorphism among mouse strains, and (c) T cells expressing the V beta 2 or V beta 10 gene segments are not subject to major clonal deletion events induced by the major histocompatibility complex class II and Mls products which were tested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660813     DOI: 10.1002/eji.1830211220

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Identification of amino acid residues of the T-cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbeta11(+) Th1 cells.

Authors:  A Kariyone; K Higuchi; S Yamamoto; A Nagasaka-Kametaka; M Harada; A Takahashi; N Harada; K Ogasawara; K Takatsu
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Derivation of T-cell receptor alpha-chain double expresser lines from normal murine mature T cells.

Authors:  K Eshima; H Suzuki; S Yamazaki; N Shinohara
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.

Authors:  T Crompton; R K Lees; H Pircher; H R MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.

Authors:  P Velupillai; I Yoshizawa; D C Dey; S R Nahill; J P Carroll; R T Bronson; T L Benjamin
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Predominant T-cell receptor Vbeta usage of intraepithelial lymphocytes during the immune response to enteric reovirus infection.

Authors:  D Chen; F Lee; J J Cebra; D H Rubin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues.

Authors:  D Velin; G Fotopoulos; J P Kraehenbuhl; H Acha-Orbea
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen.

Authors:  M Lafon; D Scott-Algara; P N Marche; P A Cazenave; E Jouvin-Marche
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

8.  Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice.

Authors:  G Strauss; D A Vignali; G Schönrich; G J Hämmerling
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Characterization of experimental allergic encephalomyelitis-susceptible, Biozzi AB/H (H-2dq1) mice which express H-2Anod: analysis of T-cell receptor expression and the detection of a deletion ligand encoded by Mtv-7.

Authors:  S Fairchild; D Baker; J L Turk
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

10.  The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.

Authors:  P Beaufils; D Choquet; R Z Mamoun; B Malissen
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.